Evidence map›Paper›PMID 28600885›Full record

ArticleMolecular reproduction and development2017

Immunolocalization of TAR DNA-binding protein of 43 kDa (TDP-43) in mouse seminiferous epithelium.

Hari Prasad Osuru, Patcharin Pramoonjago, Mayuresh M Abhyankar, Eric Swanson, LaToya Ann Roker, Helen Cathro, Prabhakara P Reddi

Open access · greenAbstract read
In one paragraph

Article in Molecular reproduction and development, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Implications of TDP-43 in non-neuronal systems.Cell communication and signaling : CCS · 2023
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hari Prasad OsuruDepartment of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia.
Patcharin PramoonjagoDepartment of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia.
Mayuresh M AbhyankarDepartment of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia.
Eric SwansonDepartment of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia.
LaToya Ann RokerDepartment of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia.
Helen CathroDepartment of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia.
Prabhakara P ReddiDepartment of Comparative Biosciences, University of Illinois at Urbana Champaign, Urbana, Illinois.ORCID http://orcid.org/0000-0003-4891-8964
University of Virginia · USUniversity of Illinois Urbana-Champaign · US

Funding

Transcriptional Regulation During SpermiogenesisR01HD036239 · NICHD · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI REDDI, PRABHAKARA P · 2004 to 2010
$1.5M
NICHD NIH HHS R01 HD036239
6 · The paper itself

Abstract

TAR DNA-binding protein of 43 kDa (TDP-43) is an evolutionarily conserved, ubiquitously expressed, multi-functional DNA/RNA-binding protein with roles in gene transcription, mRNA splicing, stability, transport, micro RNA biogenesis, and suppression of transposons. Aberrant expression of TDP-43 in testis and sperm was recently shown to be associated with male infertility, which highlights the need to understand better the expression of TDP-43 in the testis. We previously cloned TDP-43 from a mouse testis cDNA library, and showed that it functions as a transcriptional repressor and regulates the precise spatiotemporal expression of the Acrv1 gene, which encodes the acrosomal protein SP-10, during spermatogenesis. Here, we performed immunoblotting and immunohistochemistry of the mouse testis using four separate antibodies recognizing the amino and carboxyl termini of TDP-43. TDP-43 is present in the nuclei of germ cells as well as Sertoli cells. TDP-43 expression begins in type B/intermediate spermatogonia, peaks in preleptotene spermatocytes, and becomes undetectable in leptotene and zygotene spermatocytes. Pachytene spermatocytes and early round spermatids again express TDP-43, but its abundance diminishes later in spermatids (at steps 5-8). Interestingly, two of the four antibodies showed TDP-43 expression in spermatids at steps 9-10, which coincides with the initial phase of the histone-to-protamine transition. Immunoreactivity patterns observed in the study suggest that TDP-43 assumes different conformational states at different stages of spermatogenesis. TDP-43 pathology has been extensively studied in the context of neurodegenerative diseases; its role in spermatogenesis warrants further detailed investigation of the involvement of TDP-43 in male infertility.

Indexed as

AnimalsDNA-Binding ProteinsGene Expression RegulationImmunohistochemistryMaleMiceMice, Inbred C57BLSeminiferous EpitheliumSpermatogenesisDNA-Binding ProteinsTardbp protein, mousefertilityregulation of gene expressionspermatogenesistestis

Identifiers

PMID28600885
PMCPMC5577912
OpenAlexW2622112187

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.